C07D 237/02
Not condensed with other rings
Official title: not condensed with other rings
C07D237/02 (Not condensed with other rings) appears on 1,664 US grants and 1,527 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,664
- Published applications
- 1,527
- Assignees
- 733
- Inventors
- 5,830
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 13 | 0 |
| 1977 | 12 | 0 |
| 1978 | 21 | 0 |
| 1979 | 14 | 0 |
| 1980 | 12 | 0 |
| 1981 | 19 | 0 |
| 1982 | 22 | 0 |
| 1983 | 15 | 0 |
| 1984 | 14 | 0 |
| 1985 | 18 | 0 |
| 1986 | 30 | 0 |
| 1987 | 39 | 0 |
| 1988 | 24 | 0 |
| 1989 | 39 | 0 |
| 1990 | 39 | 0 |
| 1991 | 36 | 0 |
| 1992 | 33 | 0 |
| 1993 | 26 | 0 |
| 1994 | 23 | 0 |
| 1995 | 28 | 0 |
| 1996 | 22 | 0 |
| 1997 | 32 | 0 |
| 1998 | 34 | 0 |
| 1999 | 34 | 0 |
| 2000 | 24 | 0 |
| 2001 | 26 | 4 |
| 2002 | 29 | 20 |
| 2003 | 22 | 44 |
| 2004 | 21 | 62 |
| 2005 | 21 | 74 |
| 2006 | 31 | 47 |
| 2007 | 42 | 45 |
| 2008 | 31 | 62 |
| 2009 | 41 | 68 |
| 2010 | 34 | 71 |
| 2011 | 36 | 67 |
| 2012 | 44 | 44 |
| 2013 | 43 | 66 |
| 2014 | 49 | 67 |
| 2015 | 78 | 69 |
| 2016 | 55 | 61 |
| 2017 | 72 | 76 |
| 2018 | 57 | 57 |
| 2019 | 44 | 55 |
| 2020 | 47 | 68 |
| 2021 | 39 | 68 |
| 2022 | 46 | 65 |
| 2023 | 34 | 86 |
| 2024 | 27 | 72 |
| 2025 | 39 | 63 |
| 2026 | 33 | 46 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- N2-arylmethyl-4-haloalkyl-pyridazin-3-one CFTR modulators for the treatment of cystic fibrosis29 Sep 2026US 12,747,215 B2Centre National de la Recherche Scientifique (CNRS)
- EAAT2 activators and methods of using thereof29 Sep 2026US 12,747,227 B2Ohio State Innovation Foundation
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Substituted pyridazine compound22 Sep 2026US 12,741,942 B2Tenvie Therapeutics, Inc.
- Heterocyclic compound1 Sep 2026US 12,723,028 B2Takeda Pharmaceutical Company Limited
- Method for Treating Phosphorus-Containing Wastewater Produced During Preparation of Sulfonamide Compound8 Oct 2026US 2026/0308035 A1Nanhai Beisha Pharmaceutical Co., Ltd.
- Compound as voltage-gated sodium channel inhibitor3 Sep 2026US 2026/0257996 A1Guangzhou Fermion Technology Co., Ltd.
- Process for the preparation of (6s,9r)-3-oxo-3,5,6,7,8,9-hexahydro-2h-6,9-epiminocyclohepta[c]pyridazine-10-carboxamide derivatives3 Sep 2026US 2026/0258043 A1Pathios Therapeutics Limited
- Pharmaceutical compositions for subcutaneous administration of levosimendan27 Aug 2026US 2026/0248785 A1Tenax Therapeutics, Inc.
- Method for preparing pyridine oxynitride compound20 Aug 2026US 2026/0242339 A1Shanghai Jemincare Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Chemical compounds as inhibitors of amyloid beta protein production110US 5,624,937 AEli Lilly and Company · 1997
- Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals99US 5,658,933 AHoechst Aktiengesellschaft · 1997
- Pyridazo[1,2-a][1,2]diazepines89US 4,512,924 AHoffmann-La Roche Inc. · 1985
- 2-amino-1,3-propanediol compound and immunosuppressant76US 5,604,229 ATaito Co., Ltd. · 1997
- 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use75US 4,816,454 ACassella Aktiengesellschaft · 1989